Embolic Stroke of Undetermined Source (ESUS) Criteria

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
esus diagnosis
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • ESUS Diagnosis Confirmed—
  • ESUS Diagnosis Not Met—
  • Inadequate Evaluation—
Direct Clinical Answer

The Embolic Stroke of Undetermined Source (ESUS) Criteria calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include stroke type non lacunar. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Diagnostic criteria for identifying embolic stroke of undetermined source after comprehensive evaluation excluding other specific stroke etiologies.

Clinical Indication

The Embolic Stroke of Undetermined Source (ESUS) Criteria is indicated for bedside clinical practice to support Diagnostic criteria for identifying embolic stroke of undetermined source after comprehensive evaluation excluding other specific stroke etiologies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: Other specific causes to exclude: arteritis, dissection, migraine/vasospasm, drug misuse, genetic disorders, hypercoagulable states..

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: The diagnosis has implications for secondary stroke prevention strategies and treatment selection..

Formula & Variables:

ESUS diagnosis requires ALL criteria to be met: (1) Non-lacunar stroke on imaging, (2) No significant atherosclerosis (≥50% stenosis), (3) No major cardioembolic source, (4) No other specific stroke cause, AND adequate diagnostic evaluation completed.

Input Parameters

NameTypeRequiredDescription
stroke_type_non_lacunarstringYesNon-lacunar stroke detected by CT or MRI (lacunar defined as subcortical infarct ≤1.5 cm or ≤2.0 cm on MRI diffusion images)
no_significant_atherosclerosisstringYesAbsence of extracranial or intracranial atherosclerosis causing ≥50% luminal stenosis in arteries supplying the area of ischemia
no_major_cardioembolic_sourcestringYesNo major cardioembolic sources identified (atrial fibrillation, intracardiac thrombus, prosthetic valve, cardiac tumors, mitral stenosis, recent MI <4 weeks, LVEF <30%, valvular vegetations, infective endocarditis)
no_other_specific_causestringYesNo other specific cause of stroke identified (arteritis, dissection, migraine/vasospasm, drug misuse, genetic disorders)
adequate_cardiac_monitoringstringYesCardiac rhythm monitoring for ≥24 hours with automated rhythm detection completed
adequate_vascular_imagingstringYesAdequate vascular imaging completed (catheter angiography, MR/CT angiography, or cervical duplex plus transcranial Doppler ultrasonography)
adequate_cardiac_imagingstringYesAdequate cardiac imaging completed (transthoracic echocardiography and/or transesophageal echocardiography)

Score Interpretation & Guidance

RangeStageDescription
—ESUS Diagnosis ConfirmedMeets all ESUS criteria
—ESUS Diagnosis Not MetDoes not meet ESUS criteria
—Inadequate EvaluationInsufficient diagnostic workup

Evidence-Based References (EBM)

  • Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429-38. doi: 10.1016/S1474-4422(13)70310-7.DOI: 10.1016/S1474-4422(13)70310-7
  • Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
  • Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K, et al. Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis. Stroke. 2015;46(8):2087-93. doi: 10.1161/STROKEAHA.115.009334.DOI: 10.1161/STROKEAHA.115.009334
  • Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, et al. Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016;11(5):526-33. doi: 10.1177/1747493016641967.DOI: 10.1177/1747493016641967
  • Diener HC, Bernstein R, Butcher K, Campbell B, Cloud G, Davalos A, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906-17. doi: 10.1056/NEJMoa1813959.DOI: 10.1056/NEJMoa1813959

Related calculators